178 related articles for article (PubMed ID: 24523788)
1. Evidence based administration of risperidone and paliperidone for the treating conduct disorder.
Ghanizadeh A
J Res Med Sci; 2013 Nov; 18(11):998-1003. PubMed ID: 24523788
[TBL] [Abstract][Full Text] [Related]
2. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Loy JH; Merry SN; Hetrick SE; Stasiak K
Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
[TBL] [Abstract][Full Text] [Related]
3. Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.
Turgay A; Binder C; Snyder R; Fisman S
Pediatrics; 2002 Sep; 110(3):e34. PubMed ID: 12205284
[TBL] [Abstract][Full Text] [Related]
4. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
Aman MG; Binder C; Turgay A
J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
[TBL] [Abstract][Full Text] [Related]
5. Paliperidone palmitate for schizophrenia.
Nussbaum AM; Stroup TS
Cochrane Database Syst Rev; 2012 Jun; (6):CD008296. PubMed ID: 22696377
[TBL] [Abstract][Full Text] [Related]
6. Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports.
Hodkinson A; Heneghan C; Mahtani KR; Kontopantelis E; Panagioti M
BMC Med; 2021 Aug; 19(1):195. PubMed ID: 34429113
[TBL] [Abstract][Full Text] [Related]
7. Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.
Snyder R; Turgay A; Aman M; Binder C; Fisman S; Carroll A;
J Am Acad Child Adolesc Psychiatry; 2002 Sep; 41(9):1026-36. PubMed ID: 12218423
[TBL] [Abstract][Full Text] [Related]
8. Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ.
Findling RL; Aman MG; Eerdekens M; Derivan A; Lyons B;
Am J Psychiatry; 2004 Apr; 161(4):677-84. PubMed ID: 15056514
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence.
Aman MG; De Smedt G; Derivan A; Lyons B; Findling RL;
Am J Psychiatry; 2002 Aug; 159(8):1337-46. PubMed ID: 12153826
[TBL] [Abstract][Full Text] [Related]
10. Treatment with paliperidone in children with behavior disorders previously treated with risperidone: an open-label trial.
Fernández-Mayoralas DM; Fernández-Jaén A; Muñoz-Jareño N; Calleja-Pérez B; Fernández-Perrone AL; Arribas SL
Clin Neuropharmacol; 2012; 35(5):227-30. PubMed ID: 22935606
[TBL] [Abstract][Full Text] [Related]
11. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
Fowler JA; Bettinger TL; Argo TR
Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262
[TBL] [Abstract][Full Text] [Related]
12. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
13. Paliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysis.
Turkoz I; Bossie CA; Lindenmayer JP; Schooler N; Canuso CM
BMC Psychiatry; 2011 Feb; 11():21. PubMed ID: 21299844
[TBL] [Abstract][Full Text] [Related]
14. An open-label extension study of the safety and efficacy of risperidone in children and adolescents with autistic disorder.
Kent JM; Hough D; Singh J; Karcher K; Pandina G
J Child Adolesc Psychopharmacol; 2013 Dec; 23(10):676-86. PubMed ID: 24350813
[TBL] [Abstract][Full Text] [Related]
15. Aripiprazole for treating irritability in children & adolescents with autism: A systematic review.
Ghanizadeh A; Tordjman S; Jaafari N
Indian J Med Res; 2015 Sep; 142(3):269-75. PubMed ID: 26458342
[TBL] [Abstract][Full Text] [Related]
16. Risperidone in the treatment of conduct disorder in preschool children without intellectual disability.
Ercan ES; Basay BK; Basay O; Durak S; Ozbaran B
Child Adolesc Psychiatry Ment Health; 2011 Apr; 5(1):10. PubMed ID: 21489232
[TBL] [Abstract][Full Text] [Related]
17. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders.
Reyes M; Buitelaar J; Toren P; Augustyns I; Eerdekens M
Am J Psychiatry; 2006 Mar; 163(3):402-10. PubMed ID: 16513860
[TBL] [Abstract][Full Text] [Related]
19. Paliperidone: a review of clinical trial data and clinical implications.
Wang SM; Han C; Lee SJ; Patkar AA; Pae CU; Fleischhacker WW
Clin Drug Investig; 2012 Aug; 32(8):497-512. PubMed ID: 22747259
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
